| << Back |
What's New? Canis now sees the inclusion of the following new topics: Anesthesia
Critical care
Oncology
Owner information
Pharmacology & Therapeutics
Surgery soft tissue
Updated
Images (40 new)
See the New and Updated items list on the What's New page for a complete list of new and updated text components and images added to Canis. |
| << Back |
An outbreak that killed six dogs, resulting in the quarantine of two Pennsylvania Society for the Prevention of Cruelty to Animals (PSPCA) shelters and a hospital, has been attributed to " strep zoo", a bacterial infection. The deaths, which began on May 27, resulted in the deaths of two dogs and another four that had to be euthanized. The deaths were intially suspected to have been caused by canine influenza, but lab results showed the true cause to be Streptococcus equi, also known as "strep zoo". Source: DVM 360 |
| << Back |
Palladia (Toceranib phosphate) has received approval by the Food and Drug Administration. The drug is the first one developed specifically for the treatment of cancer in dogs. Palladia was cleared to treat canine cutaneous mast-cell tumors, a type of cancer responsible for about one out of five cases of canine skin tumors. The drug was approved to treat tumors with or without regional lymph-node involvement. "This cancer-drug approval for dogs is an important step forward for veterinary medicine," says Bernadette Dunham, DVM, PhD, in a prepared statement. "Prior to this approval, veterinarians had to rely on human oncology drugs, without knowledge of how safe or effective they would be for dogs. Today's approval offers dog owners, in consultation with their veterinarian, an option for treatment of their dog's cancer." Palladia is a tyrosine kinase inhibitor and works by killing tumor cells and by cutting off the blood supply to the tumor. In a clinical trial, Palladia showed a statistically significant difference in tumor shrinkage when compared with an inactive substance (placebo). The most common side effects are diarrhea, decrease or loss of appetite, lameness, weight loss and blood in the stool, the FDA reports. http://www.pfizer.com/news/press_releases/pfizer_press_releases.jsp Source: DVM360 |
| << Back |
Nobivac Lyme - a unique vaccine designed to provide protection by targeting two key outer-surface proteins involved in the transmission of canine Lyme disease has just been introduced by Intervet/Schering-Plough Animal Health. The vaccine induces the production of highly specific antibodies (borreliacidal antibodies) that kill Borrelia burgdorferi by binding to outer-surface proteins (OSP) A and C, the company reports in a prepared statement. The ability of Nobivac Lyme to stimulate borreliacidal antibodies to both OspA and OspC provides an additional layer of defense against Lyme disease The new vaccine calls for two doses, two to four weeks apart, with an annual booster thereafter. Data supporting one-year duration of immunity are on file with the US Department of Agriculture, Intervet reports. Safety studies demonstrated virtually no site reactions, the company adds. For more information, go to www.intervet.com or intervetusa.com. Source: DVM360 |
| << Back |
Canine-related references from PubMed After specific requests from existing Vetstream subscribers, Canis now includes links to the popular PubMed website for searches to specific canine-related references published during the last 12 months. On the main page of each 'Browse' area of Canis you will find a news story that will take you to recent canine references from PubMed. Just click on the story title and you will be taken to the PubMed search link for that particular body system or discipline. Selecting the link within this story will instantly bring up a list of the latest published papers on that specific area, eg anesthesia or soft tissue surgery. Each search is provided courtesy of the US National Library of Medicine (NLM) and PubMed. The search is conducted at the National Library of Medicine. The National Center for Biotechnology Information's Disclaimer and Copyright. Link for Disclaimer and Copyright - http://www.ncbi.nlm.nih.gov/About/disclaimer.html |
| << Back |
Introducing Vetstream Canis In February 2002 Vetstream Inc announced the US release of Vetstream Canis, a comprehensive, peer-reviewed canine clinical information source on the Internet. Canis is peer reviewed by over 150 experts, including 50 US veterinarians. The service includes diagnostic help, treatment selection, surgery techniques, radiographic imagery, a complete veterinary drug formulary, new product information, client information factsheets and much more. Market research showed that veterinarians wanted to access Vetstream Canis via CD-ROM and also via the Internet. Vetstream believes in providing the choice to our subscribers, so veterinarians can have the choice of subscribing to the service either on CD-ROM or Internet or both. The Canis service provides veterinary professionals with a single source of high-quality peer-reviewed canine clinical content. Canis contains over 6,200 regularly updated components encompassing diseases; bacteria, viruses and parasites; laboratory medicine; surgical and diagnostic techniques; and formularies, to name just a few. The information is arranged similar to a textbook, but offers a much wider range of functions and tools, such as cross-linking related content and images, plus highlighting key points. Veterinarians can quickly access information that supports them thoroughly from presenting problems and diagnoses to selecting treatments. The service also provides owner factsheets that are convenient to retrieve during a pet owner consultation, and can be easily printed to support client communications. The multi-media format of Canis combines text, photos, video and audio, which means the information is available in a wide range of easy-to-reference formats. Subscribers receive regular updates via the Internet and/or quarterly CD-ROM. Vetstream Felis, which covers feline clinical information, is available via the Internet and/or CD-ROM from January 2003. Vetstream Equis is Vetstream's equine clinical information service and has been available on CD-ROM since 2000 (and now available via the Internet). Equis contains over 6000 regularly updated components encompassing diseases; bacteria, viruses and parasites; laboratory medicine; surgical and diagnostic techniques; and formularies as well as all product labels for horses. The concept for Vetstream began with John Grieve in the 1980's from his own experience of difficulties in finding appropriate, accurate, comprehensive, up-to-date and user-friendly information in everyday practice. Today, Vetstream Ltd, parent company of Vetstream Inc, is the world's leading provider of clinical information to the global veterinary profession. Its animal health information and the company's extensive range of innovative services adds a powerful new dimension to veterinary practices worldwide. The services are available in over 60 countries worldwide with 47 percent of UK veterinarians subscribing to Vetstream's services. The company was acquired by Intervet Holdings, b.v., a division of Akzo-Nobel in December 2000. For more information in the USA please call 1-866-VETSTREAM (838-7873) or +1 816 221 2959 or email info@vetstream.com |
| << Back |
Component Naming Conventions When searching for a particular component in the Browse area, it may not appear to be as straightforward as you first thought. This is probably due to the naming convention adopted by Vetstream. The convention may divide the title of a topic into 2 parts according to one of the following rules:
For example, if you try to search for 'cholangiohepatitis' in the Gastrohepatology Browse area, instead of looking under 'C' in the search list you will need to look under 'L' as it is named 'Liver: cholangiohepatitis' (see below). Once you become more familiar with this naming style (convention), finding what you are looking for becomes much easier. You should also be able to find the content by typing the appropriate keyword into the Quicksearch box or selecting the word in the list shown on the keyword screen. List of components showing examples of the naming rules:
|
| << Back |
Have your say on Canis Do you think there’s something that Canis does not currently cover and should do? Have you got any comments on any of the clinical information contained on Canis? Vetstream is constantly striving to keep our services up to date and to meet the needs of veterinarians around the world. Your opinions are important to us. If you have any comments or suggestions regarding Canis, please e-mail Caroline Humphries, Commissioning Editor caroline.humphries@vetstream.com or phone +44 (0) 1223 895818. |
| << Back |
Feedback made easier Note the new icon at the top of all Canis text components, next to the "Print" icon - an "envelope" labeled Feedback. Clicking on this, will bring up a feedback form on which to e-mail comments, questions and feedback about the editorial content, direct to us at Vetstream. We welcome comments from our subscribers and find feedback useful for commissioning new material, planning updates and ensuring that the information we provide is accurate, useful and kept up-to-date. |
 |  |
| Vetstream messages: | |
 | Canine-related references from PubMed |
 | Introducing Vetstream Canis |
 | Vetstream component naming conventions |
 | Have your say on Canis |
 | Feedback made easier |